Last reviewed · How we verify
NCT06191588
Intensive Therapies to Improve Manipulation in Young Children With Hemiparesis
NA trial testing INFANT CIMT/BIT in Infantile Hemiplegia in 10 participants. Completed in 20 March 2024.
20 March 2024
Quick facts
| Lead sponsor | University of Seville |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 20 December 2023 |
| Primary completion | 20 March 2024 |
| Estimated completion | 20 March 2024 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- INFANT CIMT/BIT
Conditions studied
- Infantile Hemiplegia — all drugs for Infantile Hemiplegia →
- Constraint Induced Movement Therapy — all drugs for Constraint Induced Movement Therapy →
- Family — all drugs for Family →
- Bimanual Intensive Therapy — all drugs for Bimanual Intensive Therapy →
Sponsor
University of Seville
Who can join
Adults 9 Months to 18 Months, any sex, with Infantile Hemiplegia or Constraint Induced Movement Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
mCIMT and BIT are therapies applied in children with hemiplegia which have a great evidence, but not in a early age. This research has the objective to know the effects of this therapies in infants diagnosed of infantile hemiplegia from 9 to 18 months applying 50 hours of dose for both interventions during 10 weeks, executing them at home by families.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Feasibility of Home-Based Early Infant Hybrid Therapy in Children with Unilateral Cerebral Palsy.
Palomo-Carrión R, Romay-Barrero H, Pinero-Pinto E, Romero-Galisteo RP, et al · · 2024 · cited 1× · PMID 39597871 · DOI 10.3390/jcm13226725 -
Home-based early intensive manual therapy in unilateral cerebral palsy under 2 years of age.
Palomo-Carrión R, Pinero-Pinto E, Lirio-Romero C, Romay-Barrero H, et al · · 2026 · PMID 40715358 · DOI 10.1038/s41390-025-04306-4
Verify or expand the search:
- PubMed search for NCT06191588
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Seville trials
Trials by the same sponsor.
- NCT07501273 — Analgesic Effect of a Biophotonic Foot Massage Cream · NA · not yet recruiting
- NCT07387627 — Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders · NA · not yet recruiting
- NCT07361887 — Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. · NA · recruiting
- NCT06978582 — Effectiveness and Safety of a Tele-Rehabilitation Program on Fatigue and Related Variables in Chronic Fatigue Syndrome a · NA · active not recruiting
- NCT07208045 — Cultural Adaptation, Validation, and Evaluation of the Programme for Promotion of Healthy Affective-Sexual Behaviours in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06191588 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Seville
- Last refreshed: 29 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06191588.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing